Skip to main content
Pharma Equity Group A/S logo

Pharma Equity Group A/S — Investor Relations & Filings

Ticker · BLVIS ISIN · DK0061155009 LEI · 2138008SUI4D917FKN20 CO Financial and insurance activities
Open in API
Filings indexed 1,627 across all filing types
Latest filing 2017-02-27 AGM Information
Country DK Denmark
Listing CO BLVIS

About Pharma Equity Group A/S

https://bcbsfepvision.com/

Pharma Equity Group A/S is an investment company specializing in early-stage biotechnology, life science, and MedTech companies. The group's mission is to support its portfolio companies in developing novel therapies and effective medicines for unmet medical needs. A primary investment is its subsidiary, Reponex Pharmaceuticals, a clinical-stage biopharmaceutical company focused on developing treatments for serious, acute, and chronic inflammatory diseases. The company is actively expanding its portfolio through strategic acquisitions to support its growth.

Recent filings

Filing Released Lang Actions
AGM Information 2017
AGM Information Classification · 99% confidence The document text is very short (760 characters) and is written in Danish. It explicitly discusses the deadline (March 16, 2017) for shareholders to submit written demands to include specific items on the agenda for the upcoming Annual General Meeting (ordinære generalforsamling), referencing both company bylaws (§ 5.4) and Danish Companies Act (§ 90, stk. 3). This content is directly related to the procedures and requirements for the Annual General Meeting, making it a component of AGM information or related preparatory materials. Given the options, AGM-R (AGM Information) is the most appropriate fit as it covers materials shared during or in preparation for the AGM, although it is not the final agenda or minutes.
2017-02-27 Danish
Major Shareholding Notification 2016
Major Shareholding Notification Classification · 99% confidence The document is very short (861 characters) and explicitly states it is a 'STORAKTIONÆRMEDDELELSE' (Major Shareholder Announcement) received by Blue Vision A/S, detailing that H.C.Holding Investeringsaktieselskab has increased its shareholding to 10.40% of the capital. This directly corresponds to the definition of a Major Shareholding Notification.
2016-10-26 English
Major Shareholding Notification 2016
Major Shareholding Notification Classification · 98% confidence The document is very short (883 characters) and appears to be a formal notification received by Blue Vision A/S. The content explicitly states that H.C.Holding Investeringsaktieselskab has increased its shareholding in Blue Vision A/S, resulting in a total holding of 11,307,943 shares, which corresponds to 10.40% of the share capital. This action constitutes a notification of a change in significant share ownership, crossing a threshold that requires disclosure. This aligns directly with the definition for Major Shareholding Notification (MRQ). It is not a full report, an earnings release, or a management change announcement.
2016-10-26 Danish
Interim / Quarterly Report 2016
Interim / Quarterly Report Classification · 100% confidence The document is a 'delårsrapport' (interim report) for Blue Vision A/S covering the period 1 January to 30 June 2016. It contains specific financial results (profit after tax, equity figures) and a management review of business activities, strategy, and events. Since it provides substantive financial data and analysis for a period shorter than a full fiscal year, it qualifies as an Interim/Quarterly Report (IR). H1 2016
2016-08-25 Danish
Interim / Quarterly Report 2016
Interim / Quarterly Report Classification · 100% confidence The document is a 'Delårsrapport' (Interim Report) for Blue Vision A/S covering the period from January 1 to June 30, 2016. It contains comprehensive financial statements, including a balance sheet, income statement, cash flow statement, and management commentary. It is not an announcement of a report, but the report itself, containing substantive financial data. H1 2016
2016-08-25 English
Delårsrapportering 1. halvår 2016
Interim / Quarterly Report Classification · 100% confidence The document is a 'Delårsrapportering' (Interim Report) for the first half of 2016 for Blue Vision A/S. It contains specific financial data, including the result after tax for the period, equity figures, and a detailed management discussion of business activities, strategy, and events after the reporting period. It is not merely an announcement of a report, but the report itself containing substantive financial data and analysis, fitting the definition of an Interim/Quarterly Report (IR). H1 2016
2016-08-25 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.